Checkpoint Therapeutics, Inc. Business Finance Contracts & Agreements
33 Contracts & Agreements
- Assignment Agreements (1 contract)
- Purchase Agreements (7)
- Underwriting Agreements (3)
- Warrant Agreements (22)
- Form of Securities Purchase Agreement, dated as of July 2, 2024, by and between Checkpoint Therapeutics, Inc. and the Purchaser (Filed With SEC on July 3, 2024)
- Form of Placement Agent Warrant (Filed With SEC on July 3, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 3, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on July 3, 2024)
- Form of Securities Purchase Agreement, dated as of January 27, 2024, by and between Checkpoint Therapeutics, Inc. and the Purchaser (Filed With SEC on January 30, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 30, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 30, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on January 30, 2024)
- Form of Placement Agent Warrant (Filed With SEC on October 3, 2023)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on October 3, 2023)
- Form of Securities Purchase Agreement, dated as of July 28, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchasers (Filed With SEC on July 31, 2023)
- Form of Placement Agent Warrant (Filed With SEC on July 31, 2023)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on July 31, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on July 31, 2023)
- Form of Securities Purchase Agreement, dated as of May 23, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchaser (Filed With SEC on May 24, 2023)
- Form of Placement Agent Warrant (Filed With SEC on May 24, 2023)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on May 24, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on May 24, 2023)
- Securities Purchase Agreement, dated as of March 30, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchasers (Filed With SEC on April 4, 2023)
- Form of Placement Agent Warrant (Filed With SEC on April 4, 2023)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on April 4, 2023)
- Securities Purchase Agreement, dated as of February 20, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchaser (Filed With SEC on February 22, 2023)
- Form of Placement Agent Warrant (Filed With SEC on February 22, 2023)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on February 22, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 22, 2023)
- Securities Purchase Agreement, dated as of December 14, 2022, by and between Checkpoint Therapeutics, Inc. and the Purchaser (Filed With SEC on December 16, 2022)
- Form of Placement Agent Warrant (Filed With SEC on December 16, 2022)
- Form of Series A/B Common Stock Purchase Warrant (Filed With SEC on December 16, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on December 16, 2022)
- Underwriting Agreement, entered into by and between Checkpoint Therapeutics, Inc. and H.C. Wainwright & Co., LLC, on September 17, 2020 (Filed With SEC on September 21, 2020)
- Underwriting Agreement, entered into by Checkpoint Therapeutics, Inc. on November 20, 2019, with National Securities Corporation (Filed With SEC on November 20, 2019)
- Extension dated December 29, 2017, to Option Agreement by and between Fortress Biotech, Inc. and TG Therapeutics, Inc., dated March 17, 2015 (assigned to Checkpoint Therapeutics,... (Filed With SEC on March 16, 2018)
- Underwriting Agreement, entered into by Checkpoint Therapeutics, Inc. on March 8, 2018, with National Securities Corporation (Filed With SEC on March 8, 2018)
